As the Ebola Epidemic Spreads, NanoViricides Advances Towards a Phase II Clinical Trial of NV-387 Oral Gummies as a Treatment for Ebola in DR Congo

SHELTON, CT / ACCESS Newswire / July 6, 2026 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical ...
Security Info Watch

The Hidden Identity Threat Lurking Behind APIs and Automation

Machine identities now outnumber human users across most enterprises, yet many remain unmanaged, overprivileged, and ...

SaaSpocalypse: An Imminent Demise Of SaaS Or The New Moat-Building Era?

Alexey Spas is the founder and CEO of Instinctools, a software engineering company focused on AI-powered digital solutions.

A More Than 80% Chance of a Tesla and SpaceX Merger? It Could Be a Game Changer.

Wedbush analyst Dan Ives has put the likelihood of a merger between Tesla (TSLA 7.35%) and Space Exploration Technologies ...